GUD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Knight Therapeutics Inc

Watchlist Manager

Watchlist

Price: 10.64 CAD 0.47%

Market Cap: CA$1B

K	Knight Therapeutics Inc TSX:GUD	CA
	PAM Mineral Tbk PT IDX:NICL	ID

Profitability Summary

Knight Therapeutics Inc's profitability score is 48/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Sustainable 3Y Average Gross Margin

47%

Gross Margin is Increasing

46% > 49%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-1% > 6%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-2% > 3%

Exceptional Free Cash Flow Margin

19%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 19%

Low ROE

Negative 3Y Average ROE

View All

Hide

Collapse

48 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.